Dp44mT is primarily researched for its potential in cancer therapy due to its ability to selectively chelate iron, which is crucial for cancer cell proliferation. By disrupting iron metabolism, it induces cytotoxicity in cancer cells while sparing normal cells, making it a promising candidate for targeted cancer treatment. Additionally, its role in inhibiting tumor growth and metastasis has been explored in preclinical studies. Beyond oncology, Dp44mT is also investigated for its neuroprotective properties, particularly in conditions involving iron overload, such as neurodegenerative diseases. Its multifaceted applications highlight its significance in both cancer research and neurological studies.